Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

Microbot Medical develops and distributes the LIBERTY endovascular robotic system. The company said on October 20 that its ...

ELMNT IR also became the first account on the West Coast, marking a geographic expansion which aligns with the Company’s Full ...

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, today announced that key executives and members of the Company’s commercial team ...

Microbot Medical Inc. (MBOT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

Microbot Medical (ISIN US59503A2042) was last at USD 1.12 on Nasdaq on October 7, 2026, up 4.67 percent, while its average analyst target stood at USD 6.33 after a revision. The contrast puts ...

The Company now holds 44 issued patents and 49 pending patents globally. Commercialization continues to advance across both U.S. and international markets.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Microbot Medical (MBOT) announced that it has signed a three-year exclusive commercial distribution agreement with Medtechnica to market and sell the company’s Liberty System in Israel. The company ...

Key Points] Behind the flashy news of fundraising, entrepreneurs in embodied AI are grappling with anxiety over the lack of ...

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it has signed a three-year exclusive commercial distribution ...